Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan Plus Hydrochlorothiazide in Hypertension with CV Risk Factors
NCT00171782Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of valsartan and hydrochlorothiazide in hypertension (HTN), sponsored by Novartis. Primary endpoint: Change from baseline systolic blood pressure at 8 weeks. Started Feb 2004; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00171782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171782.